HLS Therapeutics reports mixed Q2 results; reaffirms FY25 outlook
Source: SeekingAlpha
2025-08-14 08:39:49 ET
More on HLS Therapeutics
Read the full article on Seeking Alpha
For further details see:
HLS Therapeutics reports mixed Q2 results; reaffirms FY25 outlook
HLS Therapeutics Inc
NASDAQ: HLTRF
HLTRF Trading
0.0% G/L:
$3.44 Last:
100 Volume:
$3.44 Open:
HLTRF Latest News
HLTRF Stock Data
$103,778,594
19,614,853
N/A
2
N/A
Pharmaceuticals
Healthcare
CA
Etobicoke
